Detalhe da pesquisa
1.
The potential impact of novel tuberculosis vaccine introduction on economic growth in low- and middle-income countries: A modeling study.
PLoS Med
; 20(7): e1004252, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37432972
2.
The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study.
PLoS Med
; 20(1): e1004155, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36693081
3.
Target product profiles: tests for tuberculosis treatment monitoring and optimization.
Bull World Health Organ
; 101(11): 730-737, 2023 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37961060
4.
Ongoing challenges to understanding multidrug- and rifampicin-resistant tuberculosis in children versus adults.
Eur Respir J
; 57(2)2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32855219
5.
World Health Organization recommendations on the treatment of drug-resistant tuberculosis, 2020 update.
Eur Respir J
; 57(6)2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33243847
6.
Framework for the evaluation of new tests for tuberculosis infection.
Eur Respir J
; 58(2)2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33479110
7.
Advances in clinical trial design: Weaving tomorrow's TB treatments.
PLoS Med
; 17(2): e1003059, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32106220
8.
Prevalence and genetic profiles of isoniazid resistance in tuberculosis patients: A multicountry analysis of cross-sectional data.
PLoS Med
; 17(1): e1003008, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31961877
9.
Guidance for Studies Evaluating the Accuracy of Rapid Tuberculosis Drug-Susceptibility Tests.
J Infect Dis
; 220(220 Suppl 3): S126-S135, 2019 10 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31593599
10.
Building the Framework for Standardized Clinical Laboratory Reporting of Next-generation Sequencing Data for Resistance-associated Mutations in Mycobacterium tuberculosis Complex.
Clin Infect Dis
; 69(9): 1631-1633, 2019 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30883637
11.
Low prevalence of MDR-TB in Lao PDR: results from the first national anti-tuberculosis drug resistance survey.
Trop Med Int Health
; 24(4): 421-431, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30663180
12.
Global reporting on tuberculosis preventive treatment among contacts.
Eur Respir J
; 59(3)2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35086827
13.
Wider access to quality-assured rifapentine-based regimens is needed to accelerate tuberculosis prevention and care globally.
Eur Respir J
; 60(2)2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35777762
14.
A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis.
Eur Respir J
; 50(6)2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29284687
15.
Epidemiology of Drug-Resistant Tuberculosis.
Adv Exp Med Biol
; 1019: 209-220, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29116637
16.
New definitions of pre-extensively and extensively drug-resistant tuberculosis: update from the World Health Organization.
Eur Respir J
; 57(4)2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33833074
17.
World Health Organization treatment outcome definitions for tuberculosis: 2021 update.
Eur Respir J
; 58(2)2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34413124
18.
Target product profile of a molecular drug-susceptibility test for use in microscopy centers.
J Infect Dis
; 211 Suppl 2: S39-49, 2015 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25765105
19.
Collaborative Effort for a Centralized Worldwide Tuberculosis Relational Sequencing Data Platform.
Clin Infect Dis
; 61Suppl 3: S141-6, 2015 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26409275
20.
A global strategy for tuberculosis research and innovation.
Eur Respir J
; 56(5)2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33184100